Cargando…

Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study

INTRODUCTION: Data are scarce regarding the clinical factors associated with utilization of long-term care facilities among older adults with schizophrenia. OBJECTIVES: In this multicenter study, we sought to examine potential clinical differences between older adults with schizophrenia who are livi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pierre, L., Kibby, M., Sanchez Rico, M., Hanon, C., Alvarado, J., Pascal de Raykeer, R., Limosin, F., Hoertel, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479083/ http://dx.doi.org/10.1192/j.eurpsy.2023.1980

Ejemplares similares

Mortality in older adults with severe mental illness: the role of metabolic syndrome and its components
por: Abou Kassm, S., et al.
Publicado: (2023)

Antipsychotic use and 28-day Mortality in Patients Hospitalized with COVID-19: a multicenter observational retrospective study
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Retirement age does not modify the association of prior working conditions with self-rated health and mortality in retirees: results from a prospective study of retired French workers
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Multimorbidity patterns and health care utilization among older adults with schizophrenia
por: Hwong, A., et al.
Publicado: (2023)

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Respective Mediating Effects of Social Position and Work Environment on the Incidence of Common Cardiovascular Risk Factors
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France
por: Hoertel, Nicolas, et al.
Publicado: (2020)

A Case of Violent Suicide Attempt in a Context of Myxedema Psychosis following Radioiodine Treatment in a Patient with Graves' Disease
por: Todorov, Louise, et al.
Publicado: (2019)

Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort
por: Airagnes, Guillaume, et al.
Publicado: (2019)

Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Severe pica in long-term schizophrenia, a case report
por: Querol, M. Martínez, et al.
Publicado: (2021)

Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study
por: Sánchez-Rico, Marina, et al.
Publicado: (2021)

Clinico-psychopathological characteristics of patients with residual states in long-term schizophrenia
por: Mitikhin, V., et al.
Publicado: (2023)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, D., et al.
Publicado: (2023)

Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
por: Limosin, Frédéric
Publicado: (2014)

S179. PROGNOSTIC UTILITY OF MULTIVARIATE MORPHOMETRY IN SCHIZOPHRENIA
por: Li, Mingli, et al.
Publicado: (2018)

Measuring Utility of VASS Elder Mistreatment Screener Within Community Dwelling U.S. Chinese Older Adults
por: Tuseth, Natalie, et al.
Publicado: (2021)

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
por: Hoertel, Nicolas, et al.
Publicado: (2023)

Cognitive impairment in treatment-refractory schizophrenia and type i diabetes. A case
por: Rodriguez, L. Soldado, et al.
Publicado: (2021)

Features of the inflammatory response at the long-term stages of juvenile schizophrenia
por: Zozulya, S. A., et al.
Publicado: (2023)

Negative symptoms and associated factors in older people with schizophrenia
por: Karoui, M., et al.
Publicado: (2023)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
por: Hoertel, N., et al.
Publicado: (2022)

T81. LONG-TERM COURSE OF COGNITIVE PERFORMANCE IN PATIENTS WITH CHRONIC SCHIZOPHRENIA
por: Martins, Thaís, et al.
Publicado: (2018)

Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample
por: Hoertel, Nicolas, et al.
Publicado: (2013)

A Multicenter Study on Clinical Outcomes of Infections within 200 Days of Liver Transplantation among Recipients Age 65 Years and Older
por: Malinis, Maricar, et al.
Publicado: (2017)

Research of time processing disorder within the investigation of specific traits of schizophrenia
por: Szendi Md Habil, I., et al.
Publicado: (2022)

First episode-psychosis: Short- and long-term outcomes and related features predicting the transition to schizophrenia
por: Jabeur, M., et al.
Publicado: (2022)

S251. QUALITY OF LIFE OF CHRONIC SCHIZOPHRENIA PATIENTS IN THE LONG TERM FOLLOW-UP
por: Mendes, Diego, et al.
Publicado: (2018)

O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
por: Hakala, Mika, et al.
Publicado: (2018)

F109. BOUNDARIES BETWEEN DEFICIT AND NONDEFICIT SCHIZOPHRENIA: LONG TERM STABILITY AND OUTCOMES
por: Mustafé, Gustavo, et al.
Publicado: (2018)

S85. THE EFFECT OF LONG-TERM SOCIAL DEPRIVATION ON EFFORT ALLOCATION PATTERN IN PATIENTS WITH SCHIZOPHRENIA
por: Chu, Min-yi, et al.
Publicado: (2018)

PM420. Additional clinical effects of long-term clozapine therapy for chronic schizophrenia
por: Seo, Young Eun, et al.
Publicado: (2016)

Long-term prediction of multidimensional social inclusion among patients with schizophrenia spectrum disorder
por: Hao, J., et al.
Publicado: (2023)

Early-onset schizophrenia: an adolescent case report
por: Alcalde-Diosdado Crespi, C., et al.
Publicado: (2023)

Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c153j7796qp3d5l61hh09aa0s5